Bristol-Myers Squibb Company

BMY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2009 FY2008
Assets
Cash & Equivalents $7.68B $7.98B
Accounts Receivable $1.90B $3.64B
Inventory $1.41B $1.77B
Total Current Assets $13.96B $14.70B
Property, Plant & Equipment $5.06B $5.41B
Goodwill $5.22B $4.83B
Intangible Assets (Excl. Goodwill) $2.87B $1.15B
Total Assets $31.01B $29.49B
Liabilities
Accounts Payable $1.71B $1.54B
Total Current Liabilities $6.31B $6.71B
Long-Term Debt $6.13B $6.59B
Total Liabilities $16.22B $17.28B
Stockholders' Equity
Retained Earnings $30.76B $22.55B
Total Stockholders' Equity $14.84B $12.24B
← Newer Page 3 of 3 Older →